| Profile | GDS1873 / 219571_s_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 170.686 | 49 |
| GSM40788 | control - Rep 2 | 458.845 | 75 |
| GSM40789 | control - Rep 3 | 385.354 | 72 |
| GSM40775 | androgen treated - Rep 1 | 386.705 | 72 |
| GSM40776 | androgen treated - Rep 2 | 124.36 | 38 |
| GSM40777 | androgen treated - Rep 3 | 329.89 | 68 |
| GSM40790 | estrogen treated - Rep 1 | 356.03 | 69 |
| GSM40791 | estrogen treated - Rep 2 | 334.75 | 67 |
| GSM40792 | estrogen treated - Rep 3 | 169.01 | 48 |
| GSM40784 | A + tamoxifen - Rep 1 | 427.285 | 73 |
| GSM40785 | A + tamoxifen - Rep 2 | 292.939 | 64 |
| GSM40786 | A + tamoxifen - Rep 3 | 176.908 | 50 |
| GSM40778 | A + anastrozole - Rep 1 | 322.099 | 68 |
| GSM40779 | A + anastrozole - Rep 2 | 440.79 | 73 |
| GSM40780 | A + anastrozole - Rep 3 | 156.781 | 46 |
| GSM40781 | A + letrozole - Rep 1 | 265.299 | 62 |
| GSM40782 | A + letrozole - Rep 2 | 437.07 | 73 |
| GSM40783 | A + letrozole - Rep 3 | 385.877 | 71 |